Glucose-Reducing Effect of the ORMD-0801 Oral Insulin Preparation in Patients with Uncontrolled Type 1 Diabetes: A Pilot Study

Open Access

Peer-reviewed

Research Article

Roy Eldor ,

* E-mail: eldorroy@yahoo.com

Affiliation Diabetes Unit, Internal Medicine, Hadassah University Hospital, Jerusalem, Israel
⨯
Ehud Arbit,

Affiliation Oramed Pharmaceuticals, Jerusalem, Israel
⨯
Asher Corcos,

Affiliation Diabetes and Endocrine Clinic, General Health Services, Affiliated to Hadassah Medical School, Jerusalem, Israel
⨯
Miriam Kidron

Affiliation Oramed Pharmaceuticals, Jerusalem, Israel
⨯

x

Viewed

Powered by Altmetric

Questions or concerns about usage data? Please let us know.

Print

Insulin
Is the Subject Area "Insulin" applicable to this article?

Thanks for your feedback.
Glucose
Is the Subject Area "Glucose" applicable to this article?

Thanks for your feedback.
Diabetes mellitus
Is the Subject Area "Diabetes mellitus" applicable to this article?

Thanks for your feedback.
Blood sugar
Is the Subject Area "Blood sugar" applicable to this article?

Thanks for your feedback.
Oral glucose suppression test
Is the Subject Area "Oral glucose suppression test" applicable to this article?

Thanks for your feedback.
HbA1c
Is the Subject Area "HbA1c" applicable to this article?

Thanks for your feedback.
Hypoglycemics
Is the Subject Area "Hypoglycemics" applicable to this article?

Thanks for your feedback.
Subcutaneous injections
Is the Subject Area "Subcutaneous injections" applicable to this article?

Thanks for your feedback.